Evonik’s high-load omega-3 powder platform, AvailOm, is now available in Argentina and Chile for the first time. The company has received approval from, INAL, Argentina’s regulatory authority, for commercialisation of AvailOm 50 High EPA, 50 High DHA, and 50 High DHA Algae, which is suitable for vegans. 

“We are proud to supply more nutraceutical companies in South America with our superior ingredient and global formulation capabilities. This latest approval is a next step to making AvailOm available throughout this region and the world,” said Gilles Razzauti, Director of Advanced Food Ingredients for Evonik’s Health Care business. According to the company, demand for omega-3 dietary supplements continues to grow strongly in Argentina. 

Omega-3 is an important ingredient in formulations for dietary supplements tailored to healthy agers, pregnant women, and other consumer groups. AvailOm is produced using Evonik’s proprietary process that combines omega-3 free fatty acids with the essential amino acid L-lysine. The complex formed can be processed into a range of dosage forms with no fishy aftertaste, the company says. 

The powders are directly compressible into tablets and provide nutraceutical companies the opportunity to develop differentiated combination products with other active ingredients such as botanicals, vitamins, proteins and minerals for enhanced performance and synergistic benefits. 

AvailOm 50 High DHA is a supplement solution designed for use during pregnancy and early motherhood and to support eye function or brain health in later stages of life. The 50 High EPA product promotes heart health, joint health and reduces inflammation, wheras the 50 High DHA Algae is suitable for vegan or vegetarians and supports cognitive and eye health. All AvailOm grades are produced from certified sustainable sources to protect marine ecosystems. 

The platform is part of a nutraceuticals portfolio comprising health ingredients, coatings, formulation services and finished dosage forms, all offered through Evonik’s Health Care business.